Blog Archive

Search This Blog

Monday, November 20, 2017

A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies (ECHO-208)

Condition:   Advanced or Metastatic Solid Tumors
Interventions:   Drug: Epacadostat;   Drug: Nivolumab;   Drug: Ipilimumab;   Drug: Lirilumab
Sponsor:   Incyte Corporation
Not yet recruiting

from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2jKBGG8

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Blog Archive

Pages

   International Journal of Environmental Research and Public Health IJERPH, Vol. 17, Pages 6976: Overcoming Barriers to Agriculture Green T...